Prawo i regulacje · 25/03/2013

DEA Proposes Alfaxalone Placement in Schedule IV of Controlled Substances Act

The Drug Enforcement Administration (DEA) is proposing the addition of alfaxalone, a medication used for sedation, to Schedule IV of the Controlled Substances Act, following a formal rulemaking process.